Several recent surveys have shown regional variations in the prevalence of Paget's disease of bone.1 2 Although this condition is believed to be common in the elderly in New Zealand3 and many patients there receive treatment for it,4 its specific prevalence has not been measured in any New Zealand community. We therefore undertook a survey to determine the radiological prevalence of Paget's disease in subjects aged 55 or older living in Dunedin.
This report confirms the association of thrombocytopenia with Whipple's disease, likely due to peripheral platelet sequestration, which resolves rapidly with treatment. In patients with a long history of unintended weight loss, Whipple's disease is a rare but important differential diagnosis as it is ultimately fatal if left untreated.
Background: There is increasing interest in two-agent single-pump intravenous infusions for anesthesia and sedation in pediatric patients. Propofol-remifentanil is one such mixture.The poor miscibility of such admixtures when remifentanil is added in very high concentrations and when the admixtures are maintained in static conditions has been demonstrated; however, these physiochemical properties have not been examined in clinically relevant concentrations or settings.
Aim:To examine if propofol-remifentanil admixtures maintain consistent remifentanil delivery when mixed in clinically relevant remifentanil concentrations and subjected to the physical effects of an actively infusing, directly-engaged syringe driver system with an extension line, as occurs when propofol-remifentanil is administered to a patient.
Methods:A propofol 10 mg.ml −1 combined with remifentanil 5 mcg.ml −1 solution was run using a Paedfusor ® propofol target-controlled infusion model for 10 kg and 20 kg children for 57 min at a target plasma concentration of 3 mcg.ml −1 through a 30 ml syringe, 180 cm minimum volume extension line, lever lock cannula, interlink injection site, and 22 g intravenous cannula into sample pots. Samples were taken at the completion of the loading bolus, 1 and 2 min postcompletion of loading bolus, and every 5 min thereafter. The remifentanil concentration in these samples was then assayed using chromatography.Results: There was no difference in the concentration of remifentanil in the samples based on the duration of infusion to the endpoint of 1 h, or on the patient weight model used. The concentration remained 5 mcg.ml −1 +/− 0.5 mcg.ml −1 per sample. The measurement uncertainty for the assay at 0.5 mcg.ml −1 is +/− 0.2 mcg.ml −1 .
Conclusion:The concentration of remifentanil was 5 mcg.ml −1 +/− 0.5 mcg.ml −1 and was consistent across 57 min of infusion, and two different pediatric weight profiles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.